Teva Pharmaceutical Industries Q4 Earnings Call Highlights [Yahoo! Finance]
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: Yahoo! Finance
Its innovative portfolio drove growth— AUSTEDO surpassed $725M in Q4 (about $2.2B FY) despite a ~$100M one-time inventory/gross-to-net benefit, while UZEDY and AJOVY posted strong double-digit gains and expanding market share. For 2026 Teva guided revenue of $16.4–$16.8B but warned of an approximately $1.1 billion Revlimid headwind Interested in Teva Pharmaceutical Industries Ltd.? Here are five stocks we like better. MarketBeat Week in Review – 02/03 - 02/07 Teva Pharmaceutical Industries (NYSE:TEVA) used its fourth-quarter 2025 earnings call to emphasize progress under its “Pivot to Growth” strategy, pointing to continued momentum in its innovative products, a stable generics base, expanding biosimilars portfolio, and ongoing balance sheet improvement. Management also outlined a milestone-rich 2026 for research and development, while discussing how one-time items affected fourth-quarter comparisons and how those dynamics factor into 2026 guidance. CEO Richard Francis said
Show less
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- Is Teva Pharmaceutical Industries Limited (TEVA) an Undervalued Stock Relative to Its Long-Term Potential? [Yahoo! Finance]Yahoo! Finance
- Barclays Raises Teva Pharmaceutical (TEVA) PT to $38 Following Strong Q4 Earnings Beat [Yahoo! Finance]Yahoo! Finance
- Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Jim Cramer Highlights Teva Pharmaceutical's Growth Under CEO Richard Francis [Yahoo! Finance]Yahoo! Finance
- Analysts See Pipeline Catalysts Driving Teva Pharmaceutical Industries Limited (TEVA)'s 2026 Growth Despite Revenue Headwinds [Yahoo! Finance]Yahoo! Finance
TEVA
Earnings
- 1/28/26 - Beat
TEVA
Sec Filings
- 2/3/26 - Form 10-K
- 1/29/26 - Form 4
- 1/29/26 - Form 4
- TEVA's page on the SEC website